These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12857015)

  • 1. Variable temperature X-ray powder diffractometry of spironolactone polymorphs.
    Liebenberg W; van Tonder EC; Dekker TG; de Villiers MM
    Pharmazie; 2003 Jun; 58(6):435-7. PubMed ID: 12857015
    [No Abstract]   [Full Text] [Related]  

  • 2. X-ray diffraction, differential scanning calorimetry and thermogravimetry combined with infrared analysis of freeze-dried prednisolone hemisuccinate.
    Claussen S; Böse M; Dittgen M
    Pharmazie; 2001 Jun; 56(6):475-6. PubMed ID: 11446168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
    Uchino T; Yasuno N; Yanagihara Y; Suzuki H
    Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of high sensitivity micro differential scanning calorimetry with X-ray powder diffractometry and FTIR spectroscopy for the characterization of pharmaceutically relevant non-crystalline materials.
    Song M; Liebenberg W; De Villiers MM
    Pharmazie; 2006 Apr; 61(4):336-40. PubMed ID: 16649550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of SBA-15 for furosemide oral delivery enhancement.
    Ambrogi V; Perioli L; Pagano C; Marmottini F; Ricci M; Sagnella A; Rossi C
    Eur J Pharm Sci; 2012 May; 46(1-2):43-8. PubMed ID: 22365882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
    Bouchard A; Jovanović N; Hofland GW; Jiskoot W; Mendes E; Crommelin DJ; Witkamp GJ
    Eur J Pharm Biopharm; 2008 Mar; 68(3):781-94. PubMed ID: 17702554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism, pseudopolymorphism, and amorphism of peracetylated alpha-, beta-, and gamma-cyclodextrins.
    Bettinetti G; Sorrenti M; Catenacci L; Ferrari F; Rossi S
    J Pharm Biomed Anal; 2006 Jun; 41(4):1205-11. PubMed ID: 16678374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal forms of atorvastatin.
    An SG; Sohn YT
    Arch Pharm Res; 2009 Jun; 32(6):933-6. PubMed ID: 19557372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of indapamide determined from powered diffraction data.
    Smrkolj M; Meden A
    Pharmazie; 2006 Dec; 61(12):999-1004. PubMed ID: 17283656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray diffraction, spectroscopic and thermal studies on a potential semiorganic NLO material: lithium bis-L-malato borate.
    Dhanuskodi S; Vasantha K
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jun; 61(8):1777-82. PubMed ID: 15863047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and characterization of 2-hydroxy-4-methoxybenzophenone single crystal using modified vertical Bridgman technique.
    Suthan T; Rajesh NP; Mahadevan CK; Bhagavannarayana G
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Feb; 78(2):771-6. PubMed ID: 21216185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of systems with amino-acids and oligosaccharides as modifiers of biopharmaceutical properties of furosemide.
    Miranda JA; Garnero C; Zoppi A; Sterren V; Ayala AP; Longhi MR
    J Pharm Biomed Anal; 2018 Feb; 149():143-150. PubMed ID: 29112903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and identification of novel impurities in spironolactone.
    Chen H; Wang YF; Yang ZD; Li YC
    J Pharm Biomed Anal; 2006 Mar; 40(5):1263-7. PubMed ID: 16242892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of seven residual solvents in spironolactone powder by SPME-HS-GC].
    Hu C; Wang Z; Yu Z; Zhang C
    Se Pu; 2004 May; 22(3):291. PubMed ID: 15712927
    [No Abstract]   [Full Text] [Related]  

  • 18. Crystallization and transitions of sulfamerazine polymorphs.
    Zhang GG; Gu C; Zell MT; Burkhardt RT; Munson EJ; Grant DJ
    J Pharm Sci; 2002 Apr; 91(4):1089-100. PubMed ID: 11948548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vibrational spectroscopic characterisation of salmeterol xinafoate polymorphs and a preliminary investigation of their transformation using simultaneous in situ portable Raman spectroscopy and differential scanning calorimetry.
    Ali HR; Edwards HG; Hargreaves MD; Munshi T; Scowen IJ; Telford RJ
    Anal Chim Acta; 2008 Jul; 620(1-2):103-12. PubMed ID: 18558130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal growth of phase matchable new organic nonlinear optical material for UV laser generation.
    Ramajothi J; Dhanuskodi S; Akkurt M
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Apr; 69(4):1271-6. PubMed ID: 17765602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.